{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:38:25Z","timestamp":1789540705390,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040314"],"award-info":[{"award-number":["UG1DA040314"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["HHSN271201400028C"],"award-info":[{"award-number":["HHSN271201400028C"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA013034"],"award-info":[{"award-number":["UG1DA013034"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UG1DA013035"],"award-info":[{"award-number":["5UG1DA013035"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1U10DA015831"],"award-info":[{"award-number":["1U10DA015831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040316"],"award-info":[{"award-number":["UG1DA040316"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA013720"],"award-info":[{"award-number":["UG1DA013720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10DA013714"],"award-info":[{"award-number":["U10DA013714"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA020024"],"award-info":[{"award-number":["UG1DA020024"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1UG1DA049436"],"award-info":[{"award-number":["1UG1DA049436"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32-AG-0276-7709"],"award-info":[{"award-number":["T32-AG-0276-7709"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.drugalcdep.2019.107732","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:33:21Z","timestamp":1573817601000},"page":"107732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Prevalence and treatment of opioid use disorders among primary care patients in six health systems"],"prefix":"10.1016","volume":"207","author":[{"given":"Gwen","family":"Lapham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Bobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail G.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Rossom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi Jo H.","family":"Yarborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Braciszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulin C.","family":"Hechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana E.","family":"Horigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Liebschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Loree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Stotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Szapocznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.drugalcdep.2019.107732_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0010","series-title":"Public Policy Statement on the Regulation of Office-Based Opioid Treatment","author":"American Society of Addiction Medicine","year":"2018"},{"issue":"12","key":"10.1016\/j.drugalcdep.2019.107732_bib0015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: a capture-recapture analysis","volume":"108","author":"Barocas","year":"2018","journal-title":"Am. J. Public Health"},{"issue":"Suppl 8","key":"10.1016\/j.drugalcdep.2019.107732_bib0020","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments","volume":"17","author":"Baser","year":"2011","journal-title":"Am. J. Manag. Care"},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107732_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/biostatistics\/kxh020","article-title":"Estimating marginal and incremental effects on health outcomes using flexible link and variance function models","volume":"6","author":"Basu","year":"2005","journal-title":"Biostatistics"},{"issue":"10","key":"10.1016\/j.drugalcdep.2019.107732_bib0030","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0035","series-title":"Opioid Overdose","author":"Center for Disease Control and Prevention","year":"2018"},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107732_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2018.8826","article-title":"Helping to end addiction over the long-term: the research plan for the NIH HEAL initiative","volume":"320","author":"Collins","year":"2018","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.drugalcdep.2019.107732_bib0045","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107732_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ADM.0000000000000368","article-title":"Effects of global payment and accountable care on medication treatment for alcohol and opioid use disorders","volume":"12","author":"Donohue","year":"2018","journal-title":"J. Addict. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107732_bib0055","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/papr.12148","article-title":"The prevalence of diagnosed opioid abuse in commercial and medicare managed care populations","volume":"14","author":"Dufour","year":"2014","journal-title":"Pain Pract."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107732_bib0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.2016.9795","article-title":"Clinical management of opioid use disorder","volume":"316","author":"Dunlap","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.drugalcdep.2019.107732_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jpain.2007.02.432","article-title":"Substance use disorders in a primary care sample receiving daily opioid therapy","volume":"8","author":"Fleming","year":"2007","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.drugalcdep.2019.107732_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107732_bib0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/08897077.2017.1296524","article-title":"The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics","volume":"38","author":"Hurstak","year":"2017","journal-title":"Subst. Abus."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107732_bib0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0090","series-title":"National Pain Strategy: A Comprehenisve Population Health-Level Strategy for Pain","author":"Interagency Pain Research Coordinating Committee","year":"2015"},{"issue":"8","key":"10.1016\/j.drugalcdep.2019.107732_bib0095","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107732_bib0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: a scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.drugalcdep.2017.06.009","article-title":"Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. National sample","volume":"178","author":"Krawczyk","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the massachusetts collaborative care model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"issue":"10","key":"10.1016\/j.drugalcdep.2019.107732_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186315","article-title":"Primary care models for treating opioid use disorders: what actually works? A systematic review","volume":"12","author":"Lagisetty","year":"2017","journal-title":"PLoS One"},{"issue":"10118","key":"10.1016\/j.drugalcdep.2019.107732_bib0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.drugalcdep.2019.107732_bib0125","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamapsychiatry.2016.1390","article-title":"Use of opioid agonist therapy for medicare patients in 2013","volume":"73","author":"Lembke","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.drugalcdep.2019.107732_bib0130","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2019.107732_bib0135","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/add.13270","article-title":"Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization","volume":"111","author":"Lo-Ciganic","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. Methadone for opioid use disorder nationally in the veterans health administration","volume":"160","author":"Manhapra","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107732_bib0145","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.drugalcdep.2019.107732_bib0150","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M16-0317","article-title":"Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients","volume":"165","author":"McNeely","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107732_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107732_bib0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the veterans health administration: facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2019.107732_bib0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the veterans health administration: is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107732_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1176\/appi.ps.201500501","article-title":"Integrating buprenorphine into an opioid treatment program: tailoring care for patients with opioid use disorders","volume":"68","author":"Polydorou","year":"2017","journal-title":"Psychiatr. Serv."},{"issue":"11","key":"10.1016\/j.drugalcdep.2019.107732_bib0180","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"issue":"16","key":"10.1016\/j.drugalcdep.2019.107732_bib0185","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMc1610830","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.drugalcdep.2019.107732_bib0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1521-0391.2013.12024.x","article-title":"Clinician beliefs and attitudes about Buprenorphine\/Naloxone diversion","volume":"22","author":"Schuman-Olivier","year":"2013","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107732_bib0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jsat.2012.03.008","article-title":"Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence","volume":"43","author":"Schwarz","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"issue":"6","key":"10.1016\/j.drugalcdep.2019.107732_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0205","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107732_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.healthpol.2011.09.004","article-title":"Multimorbidity and its measurement","volume":"103","author":"Starfield","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0215","series-title":"Medication and Counseling Treatment: Medications to Treat Opioid Addiction","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107732_bib0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0000000000000408","article-title":"Applying american society of addiction medicine performance measures in commercial health insurance and services data","volume":"12","author":"Thomas","year":"2018","journal-title":"J. Addict. Med."},{"issue":"e2","key":"10.1016\/j.drugalcdep.2019.107732_bib0225","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1136\/amiajnl-2013-001856","article-title":"Using electronic health records data to identify patients with chronic pain in a primary care setting","volume":"20","author":"Tian","year":"2013","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107732_bib0230","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2013.10.014","article-title":"Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients","volume":"46","author":"Tkacz","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services - linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"Trowbridge","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0240","series-title":"National Opioid Crisis: Help, Resources and Information","author":"U. S. Department of Health & Human Services","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0245","series-title":"Facing Addiction in America: The Surgeon General's Spotlight on Opioids","author":"U. S. Department of Health & Human Services Office of the Surgeon General","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"issue":"22","key":"10.1016\/j.drugalcdep.2019.107732_bib0255","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.107732_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1802741","article-title":"Primary care and the opioid-overdose crisis - buprenorphine myths and realities","volume":"379","author":"Wakeman","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0270","series-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.drugalcdep.2019.107732_bib0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:19:50Z","timestamp":1778631590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619305095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":55,"alternative-id":["S0376871619305095"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107732","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and treatment of opioid use disorders among primary care patients in six health systems","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107732"}}